15 April News

April 2014
Clinical Infectious Diseases;Apr2014, Vol. 58 Issue 8, pi
Academic Journal
The article offers news briefs related to microbiology as of April 2014. The avian influenza A(H7N9) outbreak is at developmental stage in China and promises to threaten surrounding countries. Wisconsin Division of Public Health (DPH) notified the city of Milwaukee Health Department (MHD) of an increase in reported cases of legionellosis in southeastern Wisconsin. The U.S. Food and Drug Administration (FDA) working to hydrate hospital patients.


Related Articles

  • FDA Warns Companies Marketing Fraudulent Therapies for Avian Flu. Smith, Liz // American Family Physician;1/15/2006, Vol. 73 Issue 2, p199 

    The article reports on the warning given by the U.S. Food and Drug Administration (FDA) to several companies claiming that their products are effective against avian influenza. The FDA is concerned about the safety or effectiveness of these products for treating or preventing avian flu. Some of...

  • Avian flu vaccine stockpiling continues. Johnsen, Michael // Drug Store News;11/7/2005, Vol. 27 Issue 15, p4 

    The article focuses on the stockpiling of avian flu vaccines in the United States. The federal government and the global pharmaceutical community is increasing its efforts to prepare for potential avian flu pandemic. The United States Food and Drug Administration has formed a rapid response team...

  • Tami-Fakes. Herper, Matthew // Forbes Asia;2/13/2006, Vol. 2 Issue 2, p18 

    The article presents information on the seizure of shipments of pills ordered online in San Francisco, California in December 2005. The confiscated pills were labeled as generic Tamiflu and has been high in demand because it could help contain a bird flu pandemic. The U.S. Food & Drug...

  • Is Longer Always Better?  // Hastings Center Report;May/Jun2008, Vol. 38 Issue 3, p10 

    The article describes a case study aimed at developing a new treatment for avian influenza. The goal is to find ways of generating and collecting viral antibodies from the blood of healthy subjects after injecting them with an avian flu vaccine approved by the U.S. Food & Drug Administration....

  • FDA Approves First US Avian Influenza Virus Vaccine.  // Pulmonary Reviews;May2007, Vol. 12 Issue 5, p14 

    The article reports on the approval of the first avian influenza virus vaccine for humans by the U.S. Food and Drug Administration. The vaccine manufactured by Sanofi Pasteur Inc. was obtained from a human strain and is intended for immunizing people 18 through 64 years of age at risk of...

  • Warning About "Bird Flu" Therapies.  // Child Health Alert;Feb2006, Vol. 24, p5 

    The article reports on a warning to consumers released by the U.S. Food and Drug Administration regarding products that are being promoted to prevent various kinds of influenza, including bird flu. The agency has sent warning letters to several firms marketing such products that are usually sold...

  • FDA Researchers Contribute Insights into Avian Flu Virus.  // BioPharm International;Jun2009, Vol. 22 Issue 6, p12 

    The article presents a study, conducted by U.S. Food and Drug Administration (FDA) researchers, rerlated to H5N1 avian influenza virus. Here, the researchers adapted a technique using genetically modified viruses to create fragments representing all of the proteins found in the bird flu virus....

  • Bird Flu Vaccine Looks Promising. Elliott, William T. // OB/GYN Clinical Alert;Aug2008, Vol. 25 Issue 4, p1 

    The article offers medical briefs in the U.S. The study conducted by researchers from Baxter Bioscience assessed the effectiveness of two dose vaccine in fighting avian flu. The U.S. Food and Drug Administration (FDA) requires pharmacy to provide a warning label on antipsychotics regarding an...

  • New drug and biological product approvals, 2007. Traynor, Kate // American Journal of Health-System Pharmacy;2/1/2008, Vol. 65 Issue 3, p190 

    The article offers news briefs related to drug approvals in the U.S. for 2008. The marketing of maraviroc, a chemokine receptor 5 (CCR5) blocker, was approved by the Food and Drug Administration (FDA) in August 2007. The FDA gave approval for three products intended for the treatment of advanced...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics